Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Dose-dependent and type-specific effects of statins on bone mineral density: The role of vitamin D and cholesterol

Azhar Yonis Ibrahim1, Anwar Yonis Ibrahim2, Nadheerah Falih Neamah1

1Department of Pharmacology and Toxicology; 2Department of Clinical Laboratory Sciences, College of Pharmacy, University of Basrah, Basrah, Iraq.

For correspondence:-  Nadheerah Neamah   Email: nadheerah.neamah@uobasrah.edu.iq

Received: 18 February 2026        Accepted: 18 May 2026        Published: 31 May 2026

Citation: Ibrahim AY, Ibrahim AY, Neamah NF. Dose-dependent and type-specific effects of statins on bone mineral density: The role of vitamin D and cholesterol. Trop J Pharm Res 2026; 25(5):657-663 doi: https://dx.doi.org/10.4314/tjpr.v25i5.7

© 2026 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate dose-dependent and type-specific relationships between statin therapy and bone mineral density (BMD) as well as the effect of vitamin D and cholesterol levels on BMD. Methods: This was a cross-sectional study of 260 patients on statin therapy conducted at Al-Sader Teaching Hospital in Basrah, South of Iraq, from January 2022 to May 2022. Data on BMD were collated using Dual-Energy X-ray Absorptiometry (DEXA T-scores). Treatment regimen and socioeconomic characteristics were collected. Furthermore, lipid profiles and serum vitamin D levels were assessed. Results: The study comprised of 48.1 % male and 51.9 % females. The most administered statin was atorvastatin (55.8 %). Also, osteoporosis (48.1 %) and vitamin D deficiency (59.4 %) were frequent. Higher statin dosages (atorvastatin) (> 20 mg/day) significantly reduced mean DEXA T-scores (p < 0.05). High blood cholesterol and vitamin D levels were significantly negatively and positively correlated, respectively (p < 0.05) with BMD. Conclusion: High-dose atorvastatin significantly reduces BMD, with significant negative and positive correlation with cholesterol and vitamin D levels, respectively.

Keywords: Bone mineral density (BMD), Dose-dependent, Hypercholesterolemia, Osteoporosis, Statins

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal: